Telisotuzumab vedotin Uses, Dosage, Side Effects and more
Telisotuzumab vedotin is under investigation in clinical trial NCT02099058 (A Study Evaluating the Safety, Pharmacokinetics (PK), and Preliminary Efficacy of ABBV-399 in Subjects With Advanced Solid Tumors.).
| Attribute | Details |
|---|---|
| Trade Name | Telisotuzumab vedotin |
| Generic | Telisotuzumab vedotin |
| Telisotuzumab vedotin Other Names | Telisotuzumab vedotin |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
